Top Page Links

Freed from regulatory shackles, drug firms step up on COVID-19 testing

  “Temporarily Unshackled Private Sector Responds to Demand for More Coronavirus Tests” By Jeffrey Singer, courtesy of the Cato Institute   I and others have attributed much of the initially flat‐​footed response of public health officials to the coronavirus pandemic to cumbersome, inflexible, and outdated regulations controlling the development and distribution of drugs and tests.   As I pointed […]